Dorothée Bossis

[Canadian Urological Association @CanUrolAssoc]

#CUA2026 #HandsonCourse 🥘🍲Reserve your spot today - you will not want to miss this exchange!
click here >>> https://t.co/cMHALbepR4
@TholomierC

[Breakthrough T1D @BreakthroughT1D]

Today marks not only the start of National Diabetes Awareness Month, aka NDAM, but also T1Day! NDAM is a great time to share your story, spread awareness about type 1 diabetes (T1D), and help people around the world #SeeT1D.

Want to learn more about how you can get involved this month? Visit https://t.co/95jOBs9GRk!

[Confederación Americana de Urología (CAU) @CAU_URO]

Advances in the Management of NMIBC: Regional Challenges and Global Perspectives
A CME-accredited educational session at the CAU 2025 congress.

October 8, 2025, 13:00 – 14:30
Convention Center, Main Hall, Main Room
Panama City, Panama
Web: https://t.co/yhWO6uVYqq

[Breakthrough T1D @BreakthroughT1D]

Our friends at @BT1DUK have launched a new film, 'What a Cure Feels Like'.

This film features real people affected by type 1 diabetes (T1D), shining a light on the relentless challenges of the condition and the hope for a cure.

#BreakthroughT1DUK #WhatACureFeelsLike #T1D

[UroToday.com @urotoday]

#FALCON: Gaining consensus on focal therapy for localized #ProstateCancer. Presentation by @Lara__Rodriguez @IMMontsouris. #SUO23 written coverage by @RKSayyid @UofT > https://t.co/W1Hulc2dn8 @UroOnc

[Lara Rodríguez Sánchez @Lara__Rodriguez]

Attending the #SUO23 conference is being incredible! Grateful for the opportunity to present Falcon's results. Huge thanks to @CAU_URO and @RSanchez_Salas for your continuos support and belief in this project @FocalSociety @UroOnc @IMMontsouris 👉 https://t.co/xstjarFDzI

[Rafael Sanchez-Salas @RSanchez_Salas]

FALCON flies strong! Comprehensive Consensus on #FocalTherapy #MovingForward @Lara__Rodriguez @CAU_URO @SIU_urology @smumexico @mcgillu @FocalSociety

[Rafael Sanchez-Salas @RSanchez_Salas]

Discussion of FALCON consensus results for #FocalTherapy https://t.co/pqFeP6ZPSo Join us!!

[The NanoKnife System @TheNanoKnife]

Please join us for a webinar to review the Falcon Consensus, a broad international Delphi Consensus creating a base for the future of Focal Therapy. Presented by @RSanchez_Salas & @Lara__Rodriguez on October 18th at 12pm EST/6pm CET. Register here: https://t.co/LIbaFwBbWV

[Rafael Sanchez-Salas @RSanchez_Salas]

#FocalTherapyConsensus: FALCON will be up for discussion soon! A pronounced effort by @Lara__Rodriguez will be presented in the upcoming days. #FocalTherapy #MovingForward @CAU_URO @ResidentesCAU @SIU_urology @IMM @mcgillu @cusm_muhc @AmerUrological

[Nathan Perlis @Nptdot]

We treated 3 men with prostate tumours with focal IRE today at Toronto General Hospital. 🙏🏼 @angiodynamics for your help! We are measuring cancer control and quality of life impact to see if this technology offers durable effect.

@UHN_Surgery @thePMCF @UofTUrology

[Lara Rodríguez Sánchez @Lara__Rodriguez]

Delphi Consensus on Focal Therapy for PCa🎯. Beyond experts' opinions we look for a wide and large number of specialists involved in PCa care! Contact us📩 @Lara__Rodriguez @RSanchez_Salas to get access to the survey!! @CAU_URO @SIU_urology

[Lara Rodríguez Sánchez @Lara__Rodriguez]

We are happy to announce that the first round of a Delphi consensus on #focaltherapy for PCa has been launched!!
The goal is to reach a consensus including both a HIGH and BROAD number of participants that will allow us to work in the same direction. @RSanchez_Salas

[Rafael Sanchez-Salas @RSanchez_Salas]

My SIU MEETING experience is just PLENTY of work. All kinds of it!! @SIU_urology OUR BIGGEST GRATITUDE TO THE CENTRAL OFFICE TEAM

[SIU-Urology @SIU_urology]

Join Dr. José Luis Domínguez-Escrig for a detailed overview of IRE for focal treatment of prostate cancer.
#SIU2021 @DominguezEscrig

[SIU-Urology @SIU_urology]

IRE: a novel approach for focal treatment of prostate cancer. Join Dr. José Luis Domínguez-Escrig to learn more in this exciting semi-live surgery session!
#SIU2021 @DominguezEscrig

[AngioDynamics, Inc. @angiodynamics]

AngioDynamics is pleased to partner with @UroOnc on the PRESERVE Study, assessing our NanoKnife System as a focal therapy option for prostate cancer patients & safety/effectiveness when used to ablate prostate tissue in intermediate-risk patients: https://t.co/t5HYi7Jpvs

[AngioDynamics, Inc. @angiodynamics]

We are grateful to be partnering with @UroOnc on the newly launched PRESERVE Study – advancing treatment options for patients with prostate cancer.

[Radiology @radiology_rsna]

Irreversible electroporation was effective and relatively safe for treatment of colorectal liver metastases less than or equal to 5 cm unsuitable for resection and thermal ablation. https://t.co/MpKzrMDYZC @MartijnMr @amsterdamumc #IRRad #InterventionalRadiology

[AngioDynamics, Inc. @angiodynamics]

We’ve created a virtual trade show booth experience for you to see what the NanoKnife System is all about. We invite you to come see how we are continuously expanding the boundaries of ablation.
Link: https://t.co/sDOD9wFskT